Treatment with the apoptosis inhibitor Asunercept reduces clone sizes in patients with lower risk Myelodysplastic Neoplasms.

MLA

Streuer, Alexander, et al. “Treatment with the Apoptosis Inhibitor Asunercept Reduces Clone Sizes in Patients with Lower Risk Myelodysplastic Neoplasms.” Annals of Hematology, vol. 103, no. 4, Apr. 2024, pp. 1221–33. EBSCOhost, https://doi.org/10.1007/s00277-024-05664-5.

APA

Streuer, A., Jann, J.-C., Boch, T., Mossner, M., Riabov, V., Schmitt, N., Altrock, E., Xu, Q., Demmerle, M., Nowak, V., Oblaender, J., Palme, I., Weimer, N., Rapp, F., Metzgeroth, G., Hecht, A., Höger, T., Merz, C., Hofmann, W.-K., … Nowak, D. (2024). Treatment with the apoptosis inhibitor Asunercept reduces clone sizes in patients with lower risk Myelodysplastic Neoplasms. Annals of Hematology, 103(4), 1221–1233. https://doi.org/10.1007/s00277-024-05664-5

Chicago

Streuer, Alexander, Johann-Christoph Jann, Tobias Boch, Maximilian Mossner, Vladimir Riabov, Nanni Schmitt, Eva Altrock, et al. 2024. “Treatment with the Apoptosis Inhibitor Asunercept Reduces Clone Sizes in Patients with Lower Risk Myelodysplastic Neoplasms.” Annals of Hematology 103 (4): 1221–33. doi:10.1007/s00277-024-05664-5.